Biohaven Pharmaceutical Holding Company Ltd. Analysis

BHVN Stock News

Popular stocks:

TOP Stocks:

Shares of other companies:

Workday

Tactile Systems Technology

Cumberland Pharmaceuticals

Lithium Americas

Gatos Silver

Martin Marietta Materials

Biohaven Pharmaceutical Holding (BHVN) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 3, 2023 (09:30)

Sector: Healthcare

The share price of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) now

What analysts predict: $33.67

52-week High/Low: $33.99 / $12.35

50/200 Day Moving Average: $26.49 / $20.1

This figure corresponds to the Average Price over the previous 50/200 days. For Biohaven Pharmaceutical Holding stocks, the 50-day moving average is the support level today.

For Biohaven Pharmaceutical Holding stocks, the 200-day moving average is the support level today.

Are you interested in Biohaven Pharmaceutical Holding Company Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biohaven Pharmaceutical Holding stock price in 2024, 2025, 2026, 2027, 2028. How much will one Biohaven Pharmaceutical Holding share be worth in 2024 - 2028?

When should I take profit in Biohaven Pharmaceutical Holding stock? When should I record a loss on Biohaven Pharmaceutical Holding stock? What are analysts' forecasts for Biohaven Pharmaceutical Holding stock? What is the future of Biohaven Pharmaceutical Holding stock? We forecast Biohaven Pharmaceutical Holding stock performance using neural networks based on historical data on Biohaven Pharmaceutical Holding stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Biohaven Pharmaceutical Holding stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Biohaven Pharmaceutical Holding shares. This happens once a day.

Historical and forecast chart of Biohaven Pharmaceutical Holding stock

The chart below shows the historical price of Biohaven Pharmaceutical Holding stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Biohaven Pharmaceutical Holding stock price can be found in the table below.

Long-term forecasts by years.

Biohaven Pharmaceutical Holding Company Ltd., a clinical stage biopharmaceutical company, is developing advanced candidate products targeting neurological diseases and rare disorders in the United States. Its clinical stage products include Rimehepant, a product that has completed phase III trials for the acute treatment and prevention of migraines; Vasegepant, which has completed phase 2/3 trials for acute treatment and prevention of migraine; and Troriluzole, which has completed phase II / III randomization and is continuing with extended trials for ataxia. The company also offers Troril uzole, which is a phase II / III clinical stage for obsessive-compulsive disorder and Alzheimer’s disease; BHV-0223, product for amyotrophic lateral sclerosis; BHV-5000, a product that has completed phase I clinical trials for neuropsychiatric disorders; and Verdiperstat, a product that is in phase III clinical trials for multiple systemic atrophy. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine assessment of migraine sufferers. The company was founded in 2013 and is headquartered in New Haven, Connecticut.

Biohaven Pharmaceutical Holding daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Dec 05	33.82	33.05	34.12	3.24
Dec 06	33.51	32.76	34.11	4.12
Dec 07	33.74	33.18	34.09	2.75
Dec 08	32.97	32.44	33.28	2.58
Dec 09	32.80	32.54	33.26	2.20
Dec 10	32.58	31.78	32.91	3.55
Dec 11	33.03	32.46	33.47	3.12
Dec 12	32.88	32.46	33.21	2.31
Dec 13	33.76	32.93	34.22	3.93
Dec 14	34.12	33.65	34.35	2.07
Dec 15	34.56	33.92	34.85	2.72
Dec 16	34.64	33.95	35.53	4.65
Dec 17	35.04	34.60	35.71	3.21
Dec 18	35.42	34.83	35.78	2.75
Dec 19	35.55	35.19	36.04	2.43
Dec 20	35.48	35.13	36.15	2.90
Dec 21	35.45	35.11	35.85	2.13
Dec 22	36.61	36.36	37.07	1.96
Dec 23	36.60	36.06	37.18	3.12
Dec 24	36.00	35.16	36.82	4.73
Dec 25	36.22	35.56	37.16	4.51
Dec 26	36.12	35.70	36.67	2.70
Dec 27	36.39	35.81	36.75	2.62
Dec 28	37.50	36.61	38.47	5.10
Dec 29	37.00	36.40	37.79	3.82
Dec 30	36.81	35.96	37.69	4.83
Dec 31	36.54	36.02	37.04	2.85
Jan 01	36.18	35.27	36.87	4.54
Jan 02	35.01	34.68	35.28	1.73
Jan 03	35.20	34.56	35.76	3.46

Biohaven Pharmaceutical Holding Daily Price Targets

Biohaven Pharmaceutical Holding Stock Forecast 12-05-2023.

Forecast target price for 12-05-2023: $33.82.
Positive dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 3.140%.
Pessimistic target level: 33.05
Optimistic target level: 34.12

Biohaven Pharmaceutical Holding Stock Forecast 12-06-2023.

Forecast target price for 12-06-2023: $33.51.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 3.956%.
Pessimistic target level: 32.76
Optimistic target level: 34.11

Biohaven Pharmaceutical Holding Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $33.74.
Positive dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 2.678%.
Pessimistic target level: 33.18
Optimistic target level: 34.09

Biohaven Pharmaceutical Holding Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $32.97.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 2.517%.
Pessimistic target level: 32.44
Optimistic target level: 33.28

Biohaven Pharmaceutical Holding Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $32.80.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 2.148%.
Pessimistic target level: 32.54
Optimistic target level: 33.26

Biohaven Pharmaceutical Holding Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $32.58.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 3.430%.
Pessimistic target level: 31.78
Optimistic target level: 32.91

BHVN (BHVN) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan.	32.48	30.12	34.76	13.36
Feb.	33.12	30.82	34.69	11.13
Mar.	31.70	28.94	33.62	13.90
Apr.	29.99	27.68	32.27	14.21
May.	26.92	25.86	28.79	10.18
Jun.	26.24	23.96	28.55	16.08
Jul.	27.17	25.22	29.11	13.35
Aug.	28.51	27.38	29.89	8.39
Sep.	28.29	27.57	29.19	5.54
Oct.	25.55	23.42	27.69	15.43
Nov.	25.61	24.82	27.47	9.64
Dec.	24.37	23.32	25.55	8.71

Full forecast for 2024

Biohaven Pharmaceutical Holding forecast for this year

Biohaven Pharmaceutical Holding Stock Prediction for Jan 2024

An downtrend is forecast for this month with an optimal target price of $32.477. Pessimistic: $30.12. Optimistic: $34.76

Biohaven Pharmaceutical Holding Stock Prediction for Feb 2024

An uptrend is forecast for this month with an optimal target price of $33.12. Pessimistic: $30.82. Optimistic: $34.69

Biohaven Pharmaceutical Holding Stock Prediction for Mar 2024

An downtrend is forecast for this month with an optimal target price of $31.6992. Pessimistic: $28.94. Optimistic: $33.62

Biohaven Pharmaceutical Holding Stock Prediction for Apr 2024

An downtrend is forecast for this month with an optimal target price of $29.9906. Pessimistic: $27.68. Optimistic: $32.27

Biohaven Pharmaceutical Holding Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $26.9226. Pessimistic: $25.86. Optimistic: $28.79

Biohaven Pharmaceutical Holding Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $26.2414. Pessimistic: $23.96. Optimistic: $28.55

Biohaven Pharmaceutical Holding Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $27.1651. Pessimistic: $25.22. Optimistic: $29.11

Biohaven Pharmaceutical Holding Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $28.5098. Pessimistic: $27.38. Optimistic: $29.89

Biohaven Pharmaceutical Holding Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $28.2903. Pessimistic: $27.57. Optimistic: $29.19

Biohaven Pharmaceutical Holding Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $25.5518. Pessimistic: $23.42. Optimistic: $27.69

Biohaven Pharmaceutical Holding Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $25.608. Pessimistic: $24.82. Optimistic: $27.47

Biohaven Pharmaceutical Holding Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $24.3686. Pessimistic: $23.32. Optimistic: $25.55

Biohaven Pharmaceutical Holding (BHVN) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	23.30	22.07	25.04	11.87
Feb	22.35	21.64	23.55	8.14
Mar	23.33	22.46	24.64	8.85
Apr	23.41	21.55	25.21	14.50
May	22.38	20.73	23.93	13.37
Jun	22.18	21.33	23.52	9.34
Jul	23.52	21.82	24.58	11.26
Aug	23.42	21.57	24.58	12.26
Sep	21.51	20.16	22.03	8.48
Oct	22.63	21.98	23.30	5.66
Nov	21.68	20.96	23.56	11.03
Dec	22.35	20.68	23.38	11.57

Full forecast for 2025

Biohaven Pharmaceutical Holding (BHVN) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	22.59	21.97	24.51	10.34
Feb	23.22	22.09	23.75	6.99
Mar	25.18	23.60	27.12	12.97
Apr	26.40	25.62	28.58	10.36
May	27.39	25.67	29.04	11.62
Jun	24.86	23.71	25.62	7.47
Jul	25.73	23.61	26.98	12.49
Aug	27.46	26.52	28.76	7.77
Sep	29.45	27.51	31.66	13.10
Oct	31.17	30.04	32.85	8.56
Nov	32.33	30.34	34.47	11.97
Dec	30.91	29.55	33.39	11.51

Full forecast for 2026

Biohaven Pharmaceutical Holding (BHVN) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	32.24	30.50	33.80	9.76
Feb	35.11	34.26	36.77	6.83
Mar	33.95	31.71	35.63	11.01
Apr	31.52	29.24	34.09	14.24
May	31.70	29.01	34.03	14.75
Jun	30.09	28.07	31.82	11.76
Jul	28.87	27.92	31.25	10.67
Aug	29.19	27.77	31.02	10.45
Sep	31.69	30.02	34.38	12.68
Oct	31.06	28.53	32.91	13.29
Nov	33.49	31.28	36.25	13.72
Dec	35.96	35.09	38.57	9.02

Full forecast for 2027

Biohaven Pharmaceutical Holding (BHVN) Monthly Stock Prediction for 2028

Month	Target	Pes.	Opt.	Vol., %
Jan	37.70	36.04	38.73	6.96
Feb	36.41	34.37	38.54	10.81
Mar	34.69	33.32	37.13	10.28
Apr	33.55	31.52	36.02	12.50
May	34.39	31.75	36.47	12.97
Jun	31.71	29.13	33.63	13.38
Jul	31.67	28.89	32.40	10.86
Aug	30.94	28.42	33.02	13.92
Sep	29.41	28.76	31.16	7.68
Oct	32.32	30.97	34.53	10.30
Nov	34.13	32.90	37.06	11.25
Dec	36.76	35.75	39.76	10.07

Full forecast for 2028

Biohaven Pharmaceutical Holding information and performance

Biohaven Pharmaceutical Holding Address

215 CHURCH STREET, NEW HAVEN, CT, US

Market Capitalization: 2 571 481 000 $

Market capitalization of the Biohaven Pharmaceutical Holding Company Ltd. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BHVN shares in the company outstanding by the market price of one share.

EBITDA: -462 190 016 $

EBITDA of Biohaven Pharmaceutical Holding is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -7.23

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -4.827

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 80084000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Canopy Growth Corp. (CGC)

Aadi Bioscience, Inc. (AADI)

Tilray, Inc. (TLRY)

Castle Biosciences, Inc. (CSTL)

Roivant Sciences Ltd. (ROIV)

Clover Health Investments, Corp. (CLOV)

Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

Enveric Biosciences, Inc. (ENVB)

CRISPR Therapeutics AG (CRSP)

McKesson Corp. (MCK)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/BHVN.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/BHVN.svg"> Biohaven Pharmaceutical Holding (BHVN) Stock Forecast for 2023 – 2026. Sell or Buy?